Cabergoline ratiopharm 2 mg Tablett

Land: Schweden

Sprache: Schwedisch

Quelle: Läkemedelsverket (Medical Products Agency)

Wirkstoff:

kabergolin

Verfügbar ab:

ratiopharm GmbH

ATC-Code:

N04BC06

INN (Internationale Bezeichnung):

cabergoline

Dosierung:

2 mg

Darreichungsform:

Tablett

Zusammensetzung:

kabergolin 2 mg Aktiv substans; laktos (vattenfri) Hjälpämne

Klasse:

Apotek

Verschreibungstyp:

Receptbelagt

Therapiebereich:

Kabergolin

Produktbesonderheiten:

Förpacknings: Burk, 15 tabletter; Burk, 16 tabletter; Burk, 20 tabletter; Burk, 96 tabletter; Burk, 40 tabletter; Burk, 14 tabletter; Burk, 32 tabletter; Burk, 90 tabletter; Burk, 60 tabletter; Burk, 28 tabletter; Burk, 30 tabletter; Burk, 100 tabletter; Burk, 2 tabletter; Burk, 50 tabletter; Burk, 48 tabletter; Burk, 8 tabletter

Berechtigungsstatus:

Godkänd

Berechtigungsdatum:

2006-06-16

Gebrauchsinformation

1
PACKAGE LEAFLET: Information for the user
CABERGOLINE RATIOPHARM 1 MG AND 2 MG, TABLETS
CABERGOLINE
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Cabergoline ratiopharm is and what it is used for
2.
What you need to know before you take Cabergoline ratiopharm
3.
How to take Cabergoline ratiopharm
4.
Possible side effects
5.
How to store Cabergoline ratiopharm
6.
Contents of the pack and other information
1.
WHAT CABERGOLINE RATIOPHARM IS AND WHAT IT IS USED FOR
Cabergoline ratiopharm belongs to a group of medicines known as
dopamine agonists. Cabergoline
ratiopharm acts in a similar way to a chemical present in the nervous
system called dopamine. Patients
with Parkinson’s disease do not have enough of this important
chemical.
Cabergoline ratiopharm 1 mg and 2 mg is used to treat Parkinson’s
disease. It can be either taken alone or
in combination with levodopa plus decarboxylase inhibitor, as second
choice following non-ergot derived
therapies.
Treatment under a specialist is required.
2.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE CABERGOLINE RATIOPHARM
DO NOT TAKE CABERGOLINE RATIOPHARM IF YOU

are allergic to cabergoline or other ergot alkaloids (e.g.
bromocriptine), or to any of the other
ingredients of this medicine (listed in section 6)

have ever been diagnosed in the past with problems described as
fibrotic reactions affecting the lungs,
back of the abdomen and kidneys or heart

will be treated with Cabergoline ratiopharm for a long period and have
or had fibrotic reactions (sc

Fachinformation

MARKNADSFÖRS EJ FÖR NÄRVARANDE.
_Produktinformation_